Skip to main content

Table 2 Studies reporting on HPV prevalence in ovarian cancer tissue

From: The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis

Author & publication year

Detection method

HPV genotypes found

Number of cases of EOC

Number of HPV positive cases

HPV prevalence (%)

Ingerslev et al. (2016) [28]

PCR

18

191

1

0.5

Al-Shabanah et al. (2013) [29]

PCR

16,18,45

100

42

42.0

Malisic et al. (2012) [30]

PCR

16

54

4

7.4

Bilyk et al. (2011) [31]

PCR

16,18

53

9

16.9

Idahl et al. (2010) [18]

PCR

 

52

0

0

Giordano et al. (2008) [32]

PCR

Not specified

50

1

2.0

Wentzensen et al. (2008) [19]

PCR

 

74

0

0

Atalay et al. (2007) [33]

PCR

16,33

94

8

8.5

Quirk et al. (2006) [20]

PCR

 

16

0

0

Yang et al. (2003) [34]

PCR

16,18

56

19

33.9

Ip et al. (2002) [35]

PCR

16,18

60

6

10

Li et al. (2002) [36]

PCR

Not specified

39

26

66.6

Antilla et al. (1999) [21]

PCR

 

98

0

0

Chen et al. (1999) [22]

PCR

 

20

0

0

Strickler et al. (1998) [37]

ELISA

16

16

1

6.2

Zimna et al. (1997) [38]

PCR

18

18

7

38.8

Anwar et al. (1996) [23]

PCR

 

3

0

0

Runnebaum et al. (1995) [24]

PCR

 

26

0

0

Trottier et al. (1995) [25]

PCR

 

22

0

0

Lai et al. (1994) [39]

PCR

16,18

18

11

61.1

Beckmann et al. (1991) [26]

PCR

 

18

0

0

de Villiers (1986) [27]

Southern blot hybridisation

 

7

0

0